Get started
SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.

SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.

No trades
See on Supercharts
Overview
Financials News Ideas

TEL1 chart

Upcoming earnings

Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪624.01 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0008EUR
Net income (FY)
‪−6.92 M‬EUR
Revenue (FY)
‪238.48 M‬EUR
Shares float
‪4.16 B‬
Beta (1Y)
1.01

About SIHUAN PHARMACEUTICAL HOLD GP LTD

Sector
Health Technology
CEO
Wei Cheng Guo
Headquarters
Beijing
Website
sihuanpharm.com
Employees (FY)
‪2.87 K‬
Founded
2001
FIGI
BBG00189WS48
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The Medical Aesthetic Products refers to the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. stocks are traded under the ticker TEL1.
SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. is going to release the next earnings report on Aug 27, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. financials in yearly and quarterly reports right on TradingView.
TEL1 net income for the last quarter is ‪−548.00 K‬ EUR, while the quarter before that showed ‪−6.57 M‬ EUR of net income which accounts for 91.65% change. Track more SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. financial stats to get the full picture.
Like other stocks, TEL1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. stock right from TradingView charts — choose your broker and connect to your account.
TEL1 reached its all-time high on Oct 14, 2014 with the price of 0.8160 EUR, and its all-time low was 0.0490 EUR and was reached on Feb 5, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 29, 2024, the company has ‪2.87 K‬ employees. See our rating of the largest employees — is SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. EBITDA is ‪3.84 M‬ EUR, and current EBITDA margin is 1.27%. See more stats in SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. financial statements.